With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing.
The NHS long-term plan contains ambitious commitments to diagnose more cancers earlier and boost prevention, but it lacks detail on tackling staff shortages.
Our new report estimates the number of cancer staff the NHS will need in the future so that people with cancer receive the best possible care.
With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
For the Prime Minister to reach her ambitions of 3 in 4 cancer patients diagnosed early in the next 10 years, NHS staff shortages must be addressed.
Ahead of this year’s political party conferences, we asked MPs to outline their ambitions for the NHS and cancer prevention, diagnosis and treatment.
The Government have published the first in a series of plans in the event of a ‘no-deal’ Brexit. But how will this affect cancer patients and research?
The number of older people diagnosed with cancer every year could rise by up to 80% in less than 20 years. The NHS must adapt now to care for them.